Yuuwa Capital
Finance · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Perth, Western Australia, AustraliaPhone Number
+61 861424778Website
www.yuuwa.com.auRevenue
<$5 MillionIndustry
About Yuuwa Capital
Yuuwa Capital Org Chart
Is Yuuwa Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Yuuwa Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Yuuwa Capital has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Yuuwa Capital launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Yuuwa Capital is spiking on competitors!
Earning: See what the market has to say on Yuuwa Capital recently announced quarterly report
Click to see if Yuuwa Capital had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Yuuwa Capital has new funding data
Congratulate Masked Content for being promoted to Masked Content at Yuuwa Capital
Recommended Actions
Reach out to Masked Content who joined Yuuwa Capital as Masked Content
Find 2 more new buyers
Compare Similar Companies to Yuuwa Capital
Compare insights from companies similar to Yuuwa Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Yuuwa Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Yuuwa Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Yuuwa Capital.
Yuuwa Capital Tech Stack
A closer look at the technologies used by Yuuwa Capital
Yuuwa Capital News & Media
PolyActiva appoints Tracy Valorie, ophthalmic industry expert and former Bausch + Lomb executive, to its Board of Directors
MELBOURNE, Australia, Oct. 30, 2020 /PRNewswire/ -- PolyActiva Pty Ltd, a clinical-stage ophthalmology biopharmaceutical company, today announced the appointment of highly experienced ophthalmic industry expert, Tracy Valorie, as a new member to the company's Board of Directors. Ms...PolyActiva Completes Recruitment in Key Phase I Glaucoma Implant Safety Study. Six-month Treatment Period Demonstrated.
CHICAGO--(BUSINESS WIRE)--PolyActiva Pty Ltd, a clinical-stage biotechnology company and leader in ocular drug delivery, has completed patient enrolment for its Phase I clinical trial to study safety and tolerability of its biodegradable, slow-release ocular implant for the treatment of glaucoma. PolyActiva’s implant has the potential to revolutionise the treatment for millions of glaucoma patients. Current glaucoma treatment requires eye drops to be administered daily, often multiple times eacPolyActiva Commences Its First Phase I Clinical Trial with Potential to Improve Daily Lives of Millions of Glaucoma Patients
MELBOURNE, Australia--(BUSINESS WIRE)--Revolutionary new glaucoma treatment, which could remove need for eye drop use, enters clinical trials with USD$12m venture capital-backing.
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Yuuwa Capital
Yuuwa is a specialist life sciences commercialization and investment firm based in Western Australia, established in 2009. The firm provides expertise and capital to identify and scale portfolio companies in the life sciences sector, connecting early-stage investors with high-quality ventures. Yuuwa's team consists of experienced founders and inves... Read More